Back | Next |
home / stock / qnrx / qnrx message board
Subject | By | Source | When |
---|---|---|---|
Not for adr | scotsand | investorshub | 08/08/2022 4:22:51 PM |
What?? | scotsand | investorshub | 08/08/2022 2:10:52 PM |
11.5Billions shares offering, this should go under 0.01. IMO | Cubanwinner | investorshub | 08/08/2022 4:27:43 AM |
Tiny float. Oversold on news. Grabbing all | scotsand | investorshub | 08/05/2022 3:16:04 PM |
Why?! | ttottip | investorshub | 08/04/2022 7:43:00 PM |
OS is less than 805,000 shares!!! I | ttottip | investorshub | 08/04/2022 5:29:32 PM |
Great prices to make money! | ttottip | investorshub | 08/04/2022 3:52:44 PM |
$QNRX The small floats are really moving | Capitalvaluetrade | investorshub | 08/04/2022 1:40:50 AM |
znewcar1: QNRX 36% v75,7M c.6131 f10,0M H.890 ML3234 | znewcar1 | investorshangout | 07/05/2022 1:12:38 AM |
What a pump and dump | 1968cuda434 | investorshub | 07/01/2022 6:11:41 PM |
DJ Quoin Pharmaceuticals Ltd. Withdraws Registration Statement for | crudeoil24 | investorshub | 07/01/2022 1:21:11 PM |
ASHBURN, Va., June 15, 2022 (GLOBE NEWSWIRE) -- | subslover | investorshub | 07/01/2022 12:27:42 PM |
HOD .94 | THEMASTERS_SON | investorshub | 06/07/2022 3:01:31 AM |
No filing AH | THEMASTERS_SON | investorshub | 06/06/2022 10:31:12 PM |
What a pump and dump piece of trash | 1968cuda434 | investorshub | 06/06/2022 8:14:37 PM |
,,,,,,,Awesome newshas to be dilution | THEMASTERS_SON | investorshub | 06/06/2022 5:55:35 PM |
,,,,,,,Awesome newshas to be dilution | THEMASTERS_SON | investorshub | 06/06/2022 5:55:34 PM |
,,,,,,,BUYING NOW 64s | THEMASTERS_SON | investorshub | 06/06/2022 4:01:14 PM |
Tomorrow, there will be no volume... typical | PennyPusher786 | investorshub | 06/06/2022 3:26:14 PM |
znewcar1: QNRX 23% v2,1M c1.83 f8,386M H1.895 Haft2.07 ML.93 | znewcar1 | investorshangout | 03/21/2022 8:31:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
Quoin Pharmaceuticals Ltd. Website:
Clinical site to be Opened in Saudi Arabia Site Currently Treating Netherton Patients Who Are Eligible for Recruitment into Quoin Studies Experienced Local Clinical Research Organization Has Been Engaged Plans for the Opening of Additional International Sites at an Advan...
ASHBURN, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will be a Bronze Sponsor for the Foundat...
Agreement will focus on the development of novel topical rapamycin (sirolimus) formulations as potential treatments for a number of rare and orphan diseases UCC’s proprietary dissolvable microneedles technology and other approaches will be utilized to optimize the local delivery ...